![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/12/2928326/0/en/LENZ-Therapeutics-Announces-Submission-of-New-Drug-Application-to-U-S-Food-and-Drug-Administration-for-LNZ100-for-the-Treatment-of-Presbyopia.html
https://www.globenewswire.com/news-release/2024/07/15/2912996/0/en/LENZ-Therapeutics-Announces-30-Million-Investment-from-Ridgeback-Capital.html
https://www.globenewswire.com/news-release/2024/06/10/2895928/0/en/LENZ-Therapeutics-to-Host-Key-Opinion-Leader-Event-on-June-18-2024.html
https://www.globenewswire.com/news-release/2024/05/30/2890687/0/en/LENZ-Therapeutics-to-Present-at-the-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/08/2878157/0/en/LENZ-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Updates.html
https://www.globenewswire.com/news-release/2024/05/01/2873596/0/en/LENZ-Therapeutics-to-Report-First-Quarter-Financial-Results-and-Business-Update-on-May-8-2024.html
https://endpts.com/lenz-rallies-presbyopia-awareness-with-eyecare-professionals-ahead-of-fda-submission/